-+ 0.00%
-+ 0.00%
-+ 0.00%

Autonomix Medical to present long-term pancreatic cancer pain data at ECIO 2026

PUBT·04/22/2026 12:42:32
Listen to the news
Autonomix Medical to present long-term pancreatic cancer pain data at ECIO 2026
  • Autonomix Medical scheduled presentation of new long-term clinical data on its transvascular radiofrequency ablation approach for pain mitigation in pancreatic adenocarcinoma at ECIO 2026.
  • Data will be presented in future on April 29, 2026, during an oral session in Basel, Switzerland.
  • Study analysis is positioned as supporting durable pain relief potential from minimally invasive, nerve-targeted treatment delivered via vascular system.
  • Update highlights strategy to address severe, hard-to-manage pancreatic cancer pain, targeting improved quality of life.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604220842PRIMZONEFULLFEED9694525) on April 22, 2026, and is solely responsible for the information contained therein.